175 related articles for article (PubMed ID: 15147505)
1. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.
Ebadi M; Brown-Borg H; El Refaey H; Singh BB; Garrett S; Shavali S; Sharma SK
Brain Res Mol Brain Res; 2005 Mar; 134(1):67-75. PubMed ID: 15790531
[TBL] [Abstract][Full Text] [Related]
3. Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.
Sharma R; Neupane C; Pham TL; Lee M; Lee S; Lee SY; Nam MH; Kim CS; Park JB
J Neurosci; 2023 Nov; 43(46):7730-7744. PubMed ID: 37726169
[TBL] [Abstract][Full Text] [Related]
4. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Vila M; Jackson-Lewis V; Vukosavic S; Djaldetti R; Liberatore G; Offen D; Korsmeyer SJ; Przedborski S
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2837-42. PubMed ID: 11226327
[TBL] [Abstract][Full Text] [Related]
5. Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.
Garcia-Reitboeck P; Anichtchik O; Dalley JW; Ninkina N; Tofaris GK; Buchman VL; Spillantini MG
Exp Neurol; 2013 Oct; 248():541-5. PubMed ID: 23933574
[TBL] [Abstract][Full Text] [Related]
6. Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein.
Senior SL; Ninkina N; Deacon R; Bannerman D; Buchman VL; Cragg SJ; Wade-Martins R
Eur J Neurosci; 2008 Feb; 27(4):947-57. PubMed ID: 18333965
[TBL] [Abstract][Full Text] [Related]
7. The raphe nuclei are the early lesion site of gastric
Zhang C; Bo R; Zhou T; Chen N; Yuan Y
Acta Pharm Sin B; 2024 May; 14(5):2057-2076. PubMed ID: 38799632
[TBL] [Abstract][Full Text] [Related]
8. Evidence for neurogenesis in the adult mammalian substantia nigra.
Zhao M; Momma S; Delfani K; Carlen M; Cassidy RM; Johansson CB; Brismar H; Shupliakov O; Frisen J; Janson AM
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7925-30. PubMed ID: 12792021
[TBL] [Abstract][Full Text] [Related]
9. Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration.
Moreno SIG; Limani F; Ludwig I; Gilbert C; Pifl C; Hnasko TS; Steinkellner T
bioRxiv; 2024 May; ():. PubMed ID: 38746104
[TBL] [Abstract][Full Text] [Related]
10. Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein.
Kuhn M; Haebig K; Bonin M; Ninkina N; Buchman VL; Poths S; Riess O
Neurogenetics; 2007 Apr; 8(2):71-81. PubMed ID: 17318638
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Electroencephalogram Coherence between Cortex/Striatum and Midbrain Dopaminergic Regions in the Knock-Out Mice with Combined Loss of Alpha, Beta, and Gamma Synucleins.
Vorobyov V; Deev A; Chaprov K; Ninkina N
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672235
[TBL] [Abstract][Full Text] [Related]
12. Special Issue "Neurobiology of Protein Synuclein".
Toni M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542197
[TBL] [Abstract][Full Text] [Related]
13. Retraction Note: Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38625622
[No Abstract] [Full Text] [Related]
14. Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins.
Carnazza KE; Komer LE; Xie YX; Pineda A; Briano JA; Gao V; Na Y; Ramlall T; Buchman VL; Eliezer D; Sharma M; Burré J
Cell Rep; 2024 May; 43(5):114280. PubMed ID: 38758645
[No Abstract] [Full Text] [Related]
15. Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.
Al-Wandi A; Ninkina N; Millership S; Williamson SJ; Jones PA; Buchman VL
Neurobiol Aging; 2010 May; 31(5):796-804. PubMed ID: 19097673
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease.
Rostovtseva TK; Gurnev PA; Protchenko O; Hoogerheide DP; Yap TL; Philpott CC; Lee JC; Bezrukov SM
J Biol Chem; 2015 Jul; 290(30):18467-77. PubMed ID: 26055708
[TBL] [Abstract][Full Text] [Related]
17. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family.
Anwar S; Peters O; Millership S; Ninkina N; Doig N; Connor-Robson N; Threlfell S; Kooner G; Deacon RM; Bannerman DM; Bolam JP; Chandra SS; Cragg SJ; Wade-Martins R; Buchman VL
J Neurosci; 2011 May; 31(20):7264-74. PubMed ID: 21593311
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role.
Emanuele M; Chieregatti E
Biomolecules; 2015 May; 5(2):865-92. PubMed ID: 25985082
[TBL] [Abstract][Full Text] [Related]
20. Investigation of intramolecular dynamics and conformations of α-, β- and γ-synuclein.
Ducas VC; Rhoades E
PLoS One; 2014; 9(1):e86983. PubMed ID: 24489820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
